RE: Now that's a decent size buy6 Sep 2024 11:29
According to this article Mr Tennyson is boasting.
Awakn further announced that it’s chosen to now partner with Charnwood Discovery, a “respected U.K.-based provider of drug discovery services,” to help it synthesize the new compounds for further testing.
CEO Anthony Tennyson further boasted that Awakn is “making great strides in our collaboration with Graft Polymer as we move closer to developing a new class of therapeutics to tackle PTSD and other trauma-related conditions.”
“These advancements represent a major step forward in our mission to deliver more effective solutions for those suffering from mental health disorders,” Tennyson said.